FindTrial
Sign In

Comparison of high flow nasal oxygen vs non invasive ventilation in post living donor liver transplant recipients

â??Comparison of high-flow nasal oxygen therapy (HFNO) with BIPAP for post extubation management in LDLT recipients. A prospective randomized controlled pilot studyâ??.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/033989
Enrollment
60
Registered
2021-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J952- Acute pulmonary insufficiency following nonthoracic surgery

Interventions

Intervention1: HIGH FLOW NASAL OXYGEN FOR 72 HOURS POSTOPERATIVELY: HIGH FLOW NASAL OXYGEN FOR POSTOPERATIVE RESPIRATORY MANAGEMENT IN LDLT RECIPIENT Control Intervention1: NON INVASIVE VENTILATION (B

Sponsors

DEPT OF ANAESTHESIOLOGY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: post liver transplant surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
PaO2/FiO2 RATIO at 72 hours post extubationTimepoint: PaO2/FiO2 RATIO at 72 hours post extubation—

Secondary

MeasureTime frame
PaCO2 in between the two groups for 72 hours Comparison of respiratory rate in between the two groups for 72 hours Comparison of patient comfort score in between the two groups for 72 hours Time of mobilization Time to start oral feeds Development of new chest infiltrates in 72 hrs postextubatioTimepoint: 6, 12 24 36 48,60,72 Hours post extubation—

Countries

India

Contacts

Public ContactDr MADHUSUDANAN E S

Institute of Liver and Biliary Sciences

neha.dr.garg@gmail.com8383848707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026